Novo Nordisk's Chief Strategy Officer said, “We are not ruling out; if there is an appropriate target, we will also launch an acquisition in the field of obesity treatment.

Novo Nordisk's Chief Strategy Officer said, “We are not ruling out; if there is an appropriate target, we will also launch an acquisition in the field of obesity treatment.